CinCor Pharma
USEntry
2019
Hold
4yr
Exit
2023
Who owns CinCor Pharma?
CinCor Pharma was owned by Sofinnova Partners through Sofinnova Capital IX (2018 vintage) from 2019 to 2023, exited via Trade Sale. Across its history, CinCor Pharma has been through 2 private equity ownership periods, detailed in the timeline below.
Buyer identity available on Pro.
Hand-verified · updated 2026-04-21
Most recent investor
Sofinnova PartnersSofinnova Capital IX · 2018 · Life Sciences VC
2 ownership periods · full history below
Key facts
HQUnited States
SectorBiotech
Ownership history
2 ownership periods · co-invest detected
Exited
Last exited in 2023 to .
Co-invest · 2 holders · 2019 · present
Sofinnova PartnersExited 2023
2019 · 2023(4yr) · Sofinnova Capital IX · 2018 · Life Sciences VC
Trade Sale · to
MOIC
–
More from Sofinnova Capital IX
Other portfolio companies in the same fund.
Switzerland
Italy
More PE-backed in Biotech
Comparable biotech deals from other GPs.
Track CinCor Pharma
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy CinCor Pharma?
7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on CinCor Pharma.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue